
Key coalition partner quits Israeli government over military draft
The Shas ultra-Orthodox party said it was leaving over disagreements surrounding a proposed law meant to grant wide military draft exemptions to its constituents.
A second ultra-Orthodox party quit earlier this week over the same issue.
Leading a minority government would make governing a challenge for Netanyahu.
But Shas said it wouldn't work to undermine the coalition once it left and could vote with it on some laws. It also wouldn't support its collapse.
The political turmoil comes as Israel and Hamas are negotiating a US-backed ceasefire proposal for Gaza.
While the shakeup in Netanyahu's government won't necessarily derail the talks, the Israeli leader will be more susceptible to the demands of his far-right coalition partners, who oppose ending the 21-month war while Hamas remains intact.
Our journalists are working on this story and will update it as soon as more information becomes available.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Euronews
21 minutes ago
- Euronews
EU-US trade deal leaves future of pharma tariffs uncertain
The current status of tariffs on pharmaceuticals between the EU and the US remains uncertain, despite the announcement on Sunday of a new transatlantic trade agreement. The situation is particularly sensitive given the mutual dependency in the sector: the US imports large volumes of critical pharmaceuticals from the EU, while EU-based pharmaceutical companies—especially in Ireland and Denmark—rely heavily on access to the American market. Although the new trade agreement will officially enter into force on 1 August, pharmaceuticals will not be subject to a 15% tariff which will be slapped on most goods imported from the European Union to the United States. This does not mean that there won't be tariffs at all on pharmaceuticals, as the US is still conducting an investigation into imported pharmaceuticals to assess whether they threaten US national security. For this reason, pharmaceuticals were technically excluded from yesterday's formal agreement, several EU sources confirm, as the US could not commit to any decision on tariff changes, which will only come after the conclusion of that process. However, if tariffs are introduced following the investigation, the EU expects the US—under President Trump—to honour the informal understanding reached during negotiations. This includes a cap of 15% on tariffs, which the EU considers "all-inclusive", meaning it should apply even to products still under investigation, such as pharmaceuticals and semiconductors. 'I believe that this commitment will be honoured and respected in this case as well,' said EU Trade Commissioner Maroš Šefčovič during a press briefing following the deal. So, what happens after 1 August? In the short term, nothing will change. Despite earlier reports suggesting the US would impose a 15% tariff on pharmaceuticals too in line with most EU goods, that is not expected to happen immediately. 'There will be no tariffs on pharmaceuticals this Friday,' clarified a senior EU official who participated in the negotiations with President Trump in Scotland. Most pharmaceutical products traded between the EU and the US currently benefit from a 0% tariff rate under the Most-Favoured Nation (MFN) framework. This is consistent with prior US-EU trade arrangements and World Trade Organization (WTO) commitments. As a result, EU pharmaceutical exports have faced no tariff barriers when entering the US market—a condition that remained unchanged even after Trump's so-called "Liberation Day", when he announced imposing blanket tariffs on goods. Uncertain outcome of the US investigation But tariffs on pharmaceuticals are expected to come at one point. The key uncertainty revolves around the ongoing Section 232 investigation being conducted by the Trump administration. This probe, authorised under the Trade Expansion Act of 1962, is intended to assess whether imports of pharmaceuticals (and other products as well such as semiconductors) threaten US national security. The investigation's conclusions could lead to unilateral actions by the US, including higher tariffs or import restrictions, independent of the broader trade deal struck yesterday. '[During the talks] President Trump wanted to make clear that they still have full freedom to conclude the 232 investigations and to choose any policy measures as a result,' said another EU negotiator. While EU officials cannot predict the outcome of the US investigation, they believe it is nearing completion. 'These are two investigations—pharmaceuticals and semiconductors—that are pretty close to conclusion,' an official noted. If the US does impose tariffs following the investigation, the EU expects these to be capped at 15% for both sectors, in line with the political understanding reached during the trade talks. EU's bet on pharma tariffs The EU's strategy is clear: even though Trump could not legally commit yesterday to tariffs on pharmaceuticals while the investigation is ongoing, the EU insisted on a 15% ceiling across all sectors, with no exclusions for pharmaceuticals. A senior EU official added that this understanding is backed by a broader political commitment, including planned investments by pharmaceutical companies in the US and pressure from the industry on both sides of the Atlantic to collaborate more closely. 'There is a clear understanding that investments, supply chain integration, and joint R&D efforts should all fall under the special 15% regime,' the official explained. Still, the EU acknowledges that this is not yet a legally binding commitment. 'Is this a legal commitment? No, not at this stage. That would have to come through an executive order once the US concludes its investigation,' the source continued. For now, both pharmaceutical and semiconductor products remain at zero-duty 0rates. No changes will occur on 1 August, but that could change once the US finalises its Section 232 investigation.


Euronews
21 minutes ago
- Euronews
Oil prices rise on EU-US trade deal and Trump comments on Ukraine
Oil prices rose on Monday afternoon in Europe after US President Donald Trump said he would reduce the deadline for Russian President Vladimir Putin to reach a peace deal with Ukraine. WTI was up around 2.2% at $66.50 a barrel, while Brent crude oil was up around 2% at $69.80, as of 15.00 CEST. Trump issued the 50-day timeline to Putin in July, claiming that he would hit Russia with a 100% tariff if Moscow didn't end the war in Ukraine. 'I'm disappointed in President Putin, very disappointed in him. So we're going to have to look and I'm going to reduce that 50 days that I gave him to a lesser number,' Trump told reporters in Scotland on Monday. 'I think I already know the answer, what's going to happen,' Trump said. The president was preparing to meet UK Prime Minister Keir Starmer. Oil prices had risen earlier in the day on Monday as investors reacted to news of a EU-US trade deal, announced on Sunday. Among other provisions, the EU agreed to buy $750 billion of US energy products, including oil, LNG, and nuclear energy over three years. The deal means that the EU will face a 15% tariff on most of its goods when Trump's tariff deadline ends on 1 August, rather than a threatened 30% rate. European stock markets also jumped during Monday morning trading on the news, before settling in the afternoon. Trump's tariff threats have previously deflated oil prices this year as investors predicted that a potential economic slowdown could affect demand for oil. Geopolitical risk, on the other hand, has stoked prices in cases where investors have expected threats to supply. US attacks on Iran's nuclear facilities, for example, prompted a spike in oil prices in June. An OPEC+ committee meeting is taking place on Monday, where participants will decide on production policy for September. Both the International Energy Agency and the US Energy Information Administration expect a strong oil surplus next year, with supply outpacing demand. After securing a deal with the EU, Washington has now set its sights on negotiations with China. US Treasury Secretary Scott Bessent and US Trade Representative Jamieson Greer are meeting with Chinese officials, including Chinese Vice Premier He Lifeng, on Monday in Stockholm. China and the US agreed to temporarily lower reciprocal tariffs during a 90-day truce period, set to expire on 12 August. There are hopes that the two nations will be able to extend the grace period, with China currently taxing US goods at 10% and the US taxing Chinese goods at 30%.


France 24
21 minutes ago
- France 24
Major Israeli rights groups brand Gaza campaign 'genocide'
Both organisations are frequent critics of Israeli government policies, but the language in their reports issued on Monday was their most stark yet. "Nothing prepares you for the realisation that you are part of a society committing genocide. This is a deeply painful moment for us," B'Tselem executive director Yuli Novak told a news conference unveiling the two reports. "As Israelis and Palestinians who live here and witness the reality every day, we have a duty to speak the truth as clearly as possible," she said. "Israel is committing genocide against the Palestinians." A spokesman from the Israeli prime minister's office, David Mencer, denounced the allegation. "We have free speech here in Israel but we strongly reject the accusation," he said. "Our defence forces target terrorists and never civilians. Hamas is responsible for the suffering in Gaza." Israel's war in Gaza for the past 21 months began in response to an unprecedented attack by Palestinian militant group Hamas on October 7, 2023. The Israeli assault has left much of the Gaza Strip, home to more than two million Palestinians, in ruins, and according to the Hamas-run territory's health ministry has killed at least 59,921 people, most of them civilians. All Gazans have been driven from their homes at least once since the start of the war, and UN agencies warn that residents face a growing threat of famine and malnutrition. The International Court of Justice, in an interim ruling in early 2024 in a case lodged by South Africa, found it "plausible" that the Israeli offensive had violated the UN Genocide Convention. The Israeli government, backed by the United States, fiercely denies the charge and says it is fighting to defeat Hamas and to bring back Israeli hostages still held in Gaza. The reports from B'Tselem -- one of Israel's best-known rights groups -- and Physicians for Human Rights Israel argue that the war's objectives go further. B'Tselem's report cites statements from senior politicians to illustrate that Israel "is taking coordinated action to intentionally destroy Palestinian society in the Gaza Strip". Physicians for Human Rights Israel's report documents what the group says is "the deliberate and systematic destruction of Gaza's healthcare system".